Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

by Eduard E Zijlstra, Fabiana Alves, Suman Rijal, Byron Arana, Jorge Alvar
Published 2017-11-01

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

by Siddhivinayak Hirve, Marleen Boelaert, Greg Matlashewski, Dinesh Mondal, Byron Arana, Axel Kroeger, Piero Olliaro
Published 2016-08-01

A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.

by Liliana López, Liliana López, Iván Vélez, Claudia Asela, Claudia Cruz, Fabiana Alves, Sara Robledo, Byron Arana
Published 2018-07-01

Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases

by Israel Cruz, Audrey Albertini, Mady Barbeitas, Byron Arana, Albert Picado, Jose A. Ruiz-Postigo, Joseph M. Ndung'u
Published 2019-05-01

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

by Piero Olliaro, Michel Vaillant, Byron Arana, Max Grogl, Farrokh Modabber, Alan Magill, Olivier Lapujade, Pierre Buffet, Jorge Alvar
Published 2013-01-01

Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.

by Siddhivinayak Hirve, Axel Kroeger, Greg Matlashewski, Dinesh Mondal, Megha Raj Banjara, Pradeep Das, Ahmed Be-Nazir, Byron Arana, Piero Olliaro
Published 2017-10-01

Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff

by Eva-Maria Maintz, Mahbub Hassan, M. Mamun Huda, Debashis Ghosh, Md. Shakhawat Hossain, Abdul Alim, Axel Kroeger, Byron Arana, Dinesh Mondal
Published 2014-01-01

Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis

by Diana Caridha, Brian Vesely, Katrien van Bocxlaer, Byron Arana, Charles E. Mowbray, Sima Rafati, Silvia Uliana, Rosa Reguera, Mara Kreishman-Deitrick, Richard Sciotti, Pierre Buffet, Simon L. Croft
Published 2019-12-01

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.

by Seth G Thacker, Ian L McWilliams, Beatrice Bonnet, Lydia Halie, Serge Beaucage, Swaksha Rachuri, Ranadhir Dey, Robert Duncan, Farrokh Modabber, Stephen Robinson, Graeme Bilbe, Byron Arana, Daniela Verthelyi
Published 2020-02-01

Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh

by Megha Raj Banjara, Siddhivinayak Hirve, Niyamat Ali Siddiqui, Narendra Kumar, Sangeeta Kansal, M. Mamun Huda, Pradeep Das, Suman Rijal, Chitra Kumar Gurung, Paritosh Malaviya, Byron Arana, Axel Kroeger, Dinesh Mondal
Published 2012-01-01

Research priorities for elimination of visceral leishmaniasis

by Greg Matlashewski, Byron Arana, Axel Kroeger, Ahmed Be-Nazir, Dinesh Mondal, Shan Golam Nabi, Megha Raj Banjara, Murari Lal Das, Baburam Marasini, Pradeep Das, Graham Medley, Abhay Satoskar, Hira Nakhasi, Daniel Argaw, John Reeder, Piero Olliaro
Published 2014-12-01

Patients' preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study.

by Astrid C Erber, Byron Arana, Afif Ben Salah, Issam Bennis, Aicha Boukthir, María Del Mar Castro Noriega, Mamoudou Cissé, Gláucia Fernandes Cota, Farhad Handjani, Liliana López-Carvajal, Kevin Marsh, Dalila Martínez Medina, Emma Plugge, Trudie Lang, Piero Olliaro
Published 2020-02-01

Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent.

by Piero L Olliaro, Tushar A K M Shamsuzzaman, Baburam Marasini, A C Dhariwal, Ahmed Be-Nazir, Dinesh Mondal, Megha Raj Banjara, Pradeep Das, Shyam Sundar, Suman Rijal, Byron Arana, Jorge Alvar, Daniel Argaw, Rosanna W Peeling, Axel Kroeger, Greg Matlashewski
Published 2017-01-01

Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study

by Dr. Dinesh Mondal, PhD, Jorge Alvar, PhD, Md Golam Hasnain, MPH, Md Shakhawat Hossain, MA, Debashis Ghosh, MS, M Mamun Huda, MS, Shah Golam Nabi, MPHM, Prof. Shyam Sundar, PhD, Prof. Greg Matlashewski, PhD, Byron Arana, PhD
Published 2014-01-01

Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.

by Piero Olliaro, Max Grogl, Marina Boni, Edgar M Carvalho, Houda Chebli, Mamoudou Cisse, Ermias Diro, Gláucia Fernandes Cota, Astrid C Erber, Endalamaw Gadisa, Farhad Handjani, Ali Khamesipour, Alejandro Llanos-Cuentas, Liliana López Carvajal, Lise Grout, Badre Eddine Lmimouni, Mourad Mokni, Mohammad Sami Nahzat, Afif Ben Salah, Yusuf Ozbel, Juan Miguel Pascale, Nidia Rizzo Molina, Joelle Rode, Gustavo Romero, José Antonio Ruiz-Postigo, Nancy Gore Saravia, Jaime Soto, Soner Uzun, Vahid Mashayekhi, Ivan Dario Vélez, Florian Vogt, Olga Zerpa, Byron Arana
Published 2018-01-01